|
Briefing
|
- Watson for Genomics – IBM partnering with Illumina to integrate Watson with next generation sequencing platform TruSight Tumor 170, enabling faster genomic data interpretation and analysis
- Improved Performance – Watson can produce reports on genetic alterations within minutes, instead of one week requirement for existing methods
- Cancer Research Aid – Analyzing genomic basis of tumor can help understand different types of cancer, one of leading causes of death worldwide
|
|
Accelerator
|
|
|
Business Model and Practices
Business Model
and Practices
|
|
|
Source
|
|
|
Original Publication Date
|
January 9, 2017
|
